Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
Technology
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/75/47/e2/7547e246-2aa7-0ae9-8206-cf51b7a4386d/mza_7984666269243608513.jpg/600x600bb.jpg
BioLogic
Broad Institute of MIT and Harvard
10 episodes
9 months ago
John Doench, associate director of the Genetic Perturbation Platform (GPP) and institute scientist at the Broad Institute, and Ruth Hanna, research associate in GPP, discuss how the CRISPR system has revolutionized studies of gene function.
Show more...
Science
RSS
All content for BioLogic is the property of Broad Institute of MIT and Harvard and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
John Doench, associate director of the Genetic Perturbation Platform (GPP) and institute scientist at the Broad Institute, and Ruth Hanna, research associate in GPP, discuss how the CRISPR system has revolutionized studies of gene function.
Show more...
Science
https://i1.sndcdn.com/artworks-000210043277-s4dyes-t3000x3000.jpg
BioLogic: Structural variation and disease in the human genome, with Steve McCarroll
BioLogic
7 minutes 38 seconds
8 years ago
BioLogic: Structural variation and disease in the human genome, with Steve McCarroll
Steve McCarroll, an institute member at the Broad Institute, director of genetics for the Stanley Center for Psychiatric Genetics, and an associate professor at Harvard Medical School, takes us beyond single base-pair deletions and misspellings to explore variations in the human genome on a structural level. With the analytical tools available today to examine huge lengths of DNA, McCarroll and others are linking these structural differences to human health and our risk of developing diseases such as schizophrenia and cancer.
BioLogic
John Doench, associate director of the Genetic Perturbation Platform (GPP) and institute scientist at the Broad Institute, and Ruth Hanna, research associate in GPP, discuss how the CRISPR system has revolutionized studies of gene function.